Conclusions:
Reverse axillary mapping can be used to identify the arm lymphatics in the ipsilateral axilla and these nodes are found to be free of metastatic disease in early stage breast cancer.
I. Background
Lymphatic drainage of the breast and ipsilateral upper limb is through the axilla. Majority of the cases, the two lymphatic pathways are different [1] Technique, that can differentially identify the upper limb lymphatic in the axilla can help preventing disruption of arm lymphatics at the time of axillary dissection for breast cancer. This may help reduce lymphedema, the most significant morbidity associated with surgical management of breast cancer. Reverse axillary mapping (RAM) technique, is a recent development, aimed at identifying the arm lymphatics in axilla at the time of axillary surgery for carcinoma breast. Various techniques have been described for the same -using blue dye ,radioisotope or fluorescence imaging [2] [3] [4] [5] . Although arm and breast lymphatics have been postulated to have differential drainage crossover has been documented in 2-18% [1, [5] [6] [7] with pathologically proven involvement of nodes draining the arm by metastatic carcinoma from breast in 0-43% [5, [7] [8] [9] [10] [11] . Most common complication associated with this procedure has been local tattoing lasting from few weeks to as long as 6 months. We aim to evaluate the efficacy of identification of arm lymphatic using low volume methylene blue injection (1-1.5 ml) and the degree of involvement of RAM identified nodes by metastatic disease among women with early stage breast cancer.
II. Methods
The study was conducted as a prospective non randomised study. It was conducted in the Division of breast oncology, Department of Surgical oncology at our tertiary care centre.
III. Results
The median age of patients included was 51.44 years (34-60 years). Three of the 18 patients had underwent excision biopsy outside. Thirteen patients has clinically T2 lesion and 3 patients had clinically T1 lesions. Based on location of the primary tumour, upper outer quadrant (11) was the most common location, followed by upper inner quadrant (4), lower outer quadrant (1), lower inner quadrant(1) and central sector (1) . Preoperative diagnosis of malignancy was available for all the patients (fine aspiration cytology (4), core needle biopsy (11) and slide review (3)). Intra ductal carcinoma NOS was the most common histology, one with neuroendocrine differentiation one with poorly differentiated carcinoma with neuro endocrine differentiation. Sixteen patients had grade 3 tumours, 2 patients with grade 2 tumours ( Table 1) . Modified radical mastectomy was performed in 15 of 18 patients, breast conservation surgery in 2 patients and axillary lymph node dissection(ALND) alone in one patient . Mean time from injection to axillary dissection was 41.07 minutes. Mean lymph node yield was 17.9 (range 11-32). Five patients had positive nodes in axilla on final histopathological assessment [pN1 in two ( one and two nodes positive ), pN3 in 3 patients(10,12 and 16 nodes positive)].All the three patients with pN3 could be identified intra operatively as suspicious of having high nodal involvement. Blue lymphatics(RAM lymphatics) were identified in 13 out of 18 patients (72.22%) and blue lymphnodes were identified in 11 of 18 patients (61.11%).Mean duration between the injection and start of axillary dissection was41.27 minutes. The blue nodes/lymphatics were most commonly located within a centimetre below the axillary vein , just lateral to thoracodorsal pedicle (9/11 patients) , anterior to the axillary vein(1) and just inferior to the vein (1). (Fig 1) Mean yield of blue lymph node was 1.83 (range 1-3). The size of the blue lymphnode was variable ranging from 4 mm to 1.7 cm . Only one of the 11 patients in whom RAM lymph node was identified and removed, was positive for metastatic disease( had a high axillary nodal disease, pN3) (Fig 2) .Four of the 18 patients had minimal staining at the injection site, two patients complained of minimal pain at first review (2 weeks post surgery), one had a superficial epidermal loss and at the injection site .
IV. Discussion
Globally breast cancer is the most common cancer among women. The management of breast cancer has evolved over the years from most radical Halstead's Radical mastectomy through breast conservation surgery to sentinel node biopsy (SLNB), with a significant reduction in the morbidity associated with the procedure. The status of axilla is one of the most important predictors of disease outcome. Most important morbidity associated with breast cancer surgery is ipsilateral lymphedema. Lymphedema incidence has a direct relationship to the extent of axillary lymph node dissection(ALND), varying from 58.4 % with radical mastectomy [12] to as low as 5 %with sentinel lymph node techniques [13] .Though Z0011 trial showed that SLNB alone without ALND was not inferior in terms of local recurrence and survival [14] Cadaveric studies tracing the lymphatic of upper limb , has shown that there are two pathways, a superficial and deep pathway , most of which drain into a single sentry node in the axilla [15] . Post ALND, most of these pathways become fibrosed, impairing lymphatic drainage of he upper limb, with opening of new lymphatics in some patients [16] . Lymphatics from the ipsilateral upper limb and breast in breast cancer patients draining into the axilla, were found to be different in 86.7 % cases, in patients undergoing ALND [1] .
A number of techniques have been described in literature for the identification of arm lymphatics in the axilla, using blue dye [4, 6, 8] , radio isotope [9] and fluorescence [17] . Rate of Identification of arm lymphatics varies from 33.3% in initial studies to as high as 91% with use of radio isotopes, [8, 9] . In our study, using methylene blue dye injection, at the start of surgery, blue lymphatics were identified in72.2 % while blue lymph nodes could be identified in 61.1%.The pattern of distribution of arm lymphatics in axilla varies with respect to axillary vein . Bonetti et al described 5 common variations in the distribution of arm lymphatics in the axilla [6] , with most of the lymphatics and lymph node being found within the region formed by inferior margin of axillary vein and the second intercostobrachial nerve and thoraco dorsal pedicle [4, 5, 11, 17] .In our study, 69.2% of the identified arm lymphatics was within one cm inferior to axillary vein, lateral to thoraco dorsal pedicle.RAM lymphatics were successfully identified in 10 of 13 patients with negative axilla, in 2/2 patients with pN1 disease but only in 1/3 patients with pN3 disease. This may be postulated to be secondary to lymphatic obstruction by extensive disease in axilla as described in literature [9, 18] .
The mean time between injection and commencement of axillary dissection was 41.27 minutes for our patients, which was little longer than that described in literature [4, 11] . The mean nodal yield from the axillary dissection was 17.9 (range 11-32 nodes). 5 patients had positive nodes in axilla (2 had pN1 and 3 had pN3 status). During axillary dissection, intra operative findings suspicious of a high nodal yield was there in all the three patients with advanced nodal disease(pN3), a findings not documented in previous series Intra operative assessment can help in identifying such patients who may be a high risk of harbouring metastasis in the RAM lymph nodes.
A total of 21 RAM node were identified and dissected out for histological analysis. The mean RAM node yield was 1.83 (range 1-3 nodes ) same as in previous studies [4, 19] . Only one patient of 11 with RAM node identified , had metastatic disease in the RAM node (9.09%) which is lesser when compared to rate described in literature (11-25%) [10, 19] . The positive RAM node was identified in pN3 axilla(high stage axillary disease). The same pattern had been described in various studies in literature, which have shown a positive relation between high nodal positivity and chance of arm lymphatics also being involved by the disease [9, 10, 17, 19 ,20] Schunemann Jr et al, found a statistically significant association between occurrence of metastasis in RAM nodes and high nodal disease(P<.0.001) [19] . Most studies thus suggest that performing RAM in patients with high nodal disease, is not oncologically sound [10, 11, 17, 19] .
In our experience, even in patients without a preoperative suspicion of high nodal disease, intraoperative findings could correctly identify patients with high nodal disease (100% in our series), and thus RAM node preservation may be avoided in them due to high possibility of involvement by metastatic disease. Ikeda et al further suggested that intra-operative fine needle aspiration cytology(FNAC) of the RAM node could be used to predict the their involvement. In their series, of the 7 patients with RAM node involvement, 5 were correctly identified as positive /suspicious on FNAC, while in two FNAC was inconclusive. They also found no discordance between the FNAC and final histopathology report. [17] Use of blue dye injection (injection in the arm) has been found to be associated with few local morbidity, though no systemic reaction has been documented in literature. Nos et al , described persistent blue tattooing in the arm in more than 50% of patients at a median follow up of 21 months, while Bedrosian et al., described a more milder reaction. [4, 10, 11] . In our series, there were no significant morbidity or mortality, only Four of the 18 patients had minimal staining at the injection site, at two weeks post surgery, while 2 patients complained of minimal pain, one had a superficial epidermal loss and at the injection site.
V. Conclusion
Reverse axillary mapping is a relatively new technique aimed at identifying lymphatic channel from the ipsilateral arm , draining into the axilla at the time of axillary management for patients with carcinoma breast(both sentinel node and nodal dissection). Identification rates have shown to be high in recent series , many have found a overlap between the ALND field /Sentinel node and RAM node. Its involvement by metastatic disease, hence the oncological safety in preserving them has been evaluated by small trials. Due to high rate of metastatic involvement in patients with high nodal disease, it is advisable to avoid preservation of RAM nodes, in patients with an intraoperative suspicion of high nodal disease. An alternative would be do perform an intraoperative FNAC from identified RAM node to rule out its metastatic involvement. Further larger studies needs to be performed to establish unequivocally the oncological safety of preservation of RAM nodes and also to evlaluate the long term outcomes in terms of lymphedema incidence and nodal recurrence, to 
